ARCHIVES

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

This article is from The Cancer Letter archive.

Vol. 16 No. 43 | November 9, 1990

Download PDF Visit The Full Archive

Related Articles

One Year Later, Cancer Centers And NCI are Getting Along Just Fine, AACI Learns

July 27, 1990

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

Public Health Service: Scientific Papers Become “Deliverables” In Own RFP

October 3, 1997

NCI Changes Deadlines For Two RFAS

July 18, 1997

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013